Findings

What do systematic reviews say?

4,678 questions · 4,859 findings · 283 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,225 · 25.2%GRADE not reported 215 · 4.4%Very low 1,241 · 25.5%Low 1,210 · 24.9%Moderate 776 · 16%High 192 · 4%

Summary of findings: levodopa vs placebo

Quality of sleep · patients with restless legs syndrome

1 finding from 1 review

Levodopa for the treatment of restless legs syndrome 2011 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 60 participants
Moderate

Summary of findings: levodopa vs placebo

Quality of life VAS on life satisfaction (0 to 50 = high) · patients with restless legs syndrome

1 finding from 1 review

Levodopa for the treatment of restless legs syndrome 2011 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 60 participants
Moderate

Summary of findings: levodopa vs other dopamine agonists

IRLS · patients with restless legs syndrome

1 finding from 1 review

Levodopa for the treatment of restless legs syndrome 2011 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 383 participants
Moderate

Summary of findings: levodopa vs other dopamine agonists

Periodic limb movements per hour of time in bed · patients with restless legs syndrome

1 finding from 1 review

Levodopa for the treatment of restless legs syndrome 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Low

Summary of findings: 5 mg/day vs placebo

Benefits · rotator cuff disease

The review found no eligible studies for this question.

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

Benefits · rotator cuff disease

The review found no eligible studies for this question.

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

Pain ‐ not reported1 · rotator cuff disease

The review found no eligible studies for this question.

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

Function ‐ not measured · rotator cuff disease

The review found no eligible studies for this question.

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

Harms · rotator cuff disease

The review found no eligible studies for this question.

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

Headache · rotator cuff disease

It is very uncertain whether summary of findings: 5 mg/day changes headache ( compared with injection with corticosteroid and anaesthetic (very low certainty).

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
RR 31.003 [1.96, 490.31]
1 study · 48 participants
Very low

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

Injection site pain · rotator cuff disease

It is very uncertain whether summary of findings: 5 mg/day changes injection site pain ( compared with injection with corticosteroid and anaesthetic (very low certainty).

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
RR 0.11 [0.01, 1.96]
1 study · 48 participants
Very low

Summary of findings: 5 mg/day vs placebo

Pain intensity (0‐10cm visual analogue scale) · rotator cuff disease

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Low

Summary of findings: 5 mg/day vs placebo

Symptom free ( · rotator cuff disease

It is very uncertain whether summary of findings: 5 mg/day changes symptom free ( compared with placebo (very low certainty).

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
RR 1.91 [1.04, 3.5]
1 study · 20 participants
Very low

Summary of findings: 5 mg/day vs placebo

Function ‐ not measured · rotator cuff disease

The review found no eligible studies for this question.

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: 5 mg/day vs placebo

Harms · rotator cuff disease

The review found no eligible studies for this question.

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: 5 mg/day vs placebo

Headache ‐ not reported4 · rotator cuff disease

The review found no eligible studies for this question.

1 finding from 1 review

Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Benzodiazepines (lorazepam) vs chlorpromazine

Symptoms of delirium within 24 hoursa · terminally ill adults with delirium

The review found no eligible studies for this question.

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Benzodiazepines (lorazepam) vs chlorpromazine

Symptoms of delirium between 24 and 48 hoursa · terminally ill adults with delirium

It is very uncertain whether summary of findings: lorazepam changes symptoms of delirium between 24 and 48 hoursa compared with chlorpromazine (very low certainty).

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
MD 5.25
1 study · 19 participants
Very low

Benzodiazepines (lorazepam) vs chlorpromazine

Specific behaviour ‐ agitation · terminally ill adults with delirium

The review found no eligible studies for this question.

2 findings from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Benzodiazepines (lorazepam) vs chlorpromazine

Adverse events including extrapyramidal effects · terminally ill adults with delirium

It is very uncertain whether summary of findings: lorazepam changes number of adverse events including extrapyramidal effectsc compared with chlorpromazine (very low certainty).

1 finding from 1 review

Drug therapy for delirium in terminally ill adults 2020 · Cochrane Headline outcomes only
MD 7.12
1 study · 18 participants
Very low